Drugs / MEDI7814
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01544361 | Jan → Sep 2012 | — | MedImmune LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MEDI7814 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01544361 ↗ |
| Route | Intravenous | “MEDI7814, 1 mg/kg intravenous infusion” NCT01544361 ↗ |